Papers
25
Total Citations
1,543
H-Index
16
About
Kevin Chan is a prominent urologic surgeon and researcher whose work has fundamentally advanced the field of robot-assisted radical cystectomy (RARC) for bladder cancer. His research centers on minimally invasive surgical oncology, with a particular focus on perioperative outcomes, oncologic efficacy, complication analysis, and urinary reconstruction following robotic surgery. Chan's most influential contributions include a pair of landmark 2015 systematic reviews — together accumulating nearly 670 citations — that comprehensively evaluated both the safety and oncologic outcomes of RARC, helping to establish the evidence base for widespread adoption of this technique. His involvement in the Pasadena Consensus Panel produced two highly cited guideline documents, shaping best practices and technical standards for surgeons worldwide. Earlier work standardizing complication reporting after RARC (2012–2013), stratified by urinary diversion type, filled a critical gap in the literature and provided a rigorous framework for outcome comparison across institutions. Beyond cystectomy, Chan has contributed to robot-assisted radical prostatectomy research through a prospective randomized trial examining pelvic drain omission. With over 1,300 cumulative citations, his body of work continues to inform surgical decision-making and improve patient outcomes in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10